These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 183084)

  • 1. Therapeutic failure in familial type II hyperlipoproteinemia.
    Witters LA; Herbert PN; Shulman RS; Krauss RM; Levy RI
    Metabolism; 1976 Sep; 25(9):1017-26. PubMed ID: 183084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type II primary hyperlipoproteinemia: effect of dietary treatment and cholestyramine on serum lipids and lipoproteins].
    Vaverková H; Kubasta M; Zmeskal A; Procházka J; Vrublowský P; Podivínský
    Vnitr Lek; 1976 Jan; 22(1):73-83. PubMed ID: 175564
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial and acquired hyperlipoproteinemias in children and adolescents.
    Mellies M; Glueck CJ; Fallat RW; Tsang R
    Postgrad Med; 1974 Nov; 56(6):94-100. PubMed ID: 4372590
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.
    Glueck CJ; Fallat R; Tsang R
    Pediatrics; 1973 Nov; 52(5):669-79. PubMed ID: 4355362
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary and drug treatment of primary hyperlipoproteinemia.
    Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
    [No Abstract]   [Full Text] [Related]  

  • 6. Lecithin: cholestrol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type IIa hyperlipoproteinaemia.
    Wallentin L
    Eur J Clin Invest; 1978 Dec; 8(6):383-9. PubMed ID: 217692
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 8. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achilles tendinitis and tenosynovitis. A diagnostic manifestation of familial type II hyperlipoproteinemia in children.
    Shapiro JR; Fallat RW; Tsang RC; Glueck CJ
    Am J Dis Child; 1974 Oct; 128(4):486-90. PubMed ID: 4369742
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

  • 14. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
    Angelin B; Einarsson K
    Atherosclerosis; 1981; 38(1-2):33-8. PubMed ID: 7470203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of hyperlipidemic states.
    Havel RJ; Kane JP
    Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
    Kuo PT; Hayase K; Kostis JB; Moreyra AE
    Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
    Glueck CJ; Ford S; Scheel D; Steiner P
    JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.
    Schwandt P; Richter WO; Weisweiler P; Neureuther G
    Atherosclerosis; 1982 Sep; 44(3):379-83. PubMed ID: 7150399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification and management of familial hyperlipoproteinemia.
    Wessler S; Avioli LA
    JAMA; 1969 Feb; 207(5):929-33. PubMed ID: 5818258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.